Question: I have heard that in some way COVID infection or having received the COVID vaccine is also a new risk for ...

Moderna Inc. (NASDAQ:MRNA) reported on Friday a second-quarter loss of $2.13 per share, beating the consensus of a $2.98 loss ...

Increases in COVID, RSV, and influenza are the result of governments refusal to enact public health measures and address ...

In recent years, doctors and scientists are increasingly studying long-lasting illnesses that begin after someone recovers ...

Common respiratory infections like the flu and COVID-19 might jolt dormant cancer cells back to life in survivors, causing them to multiply and spread in the lungs.

The 2025 flu season is the worst in over a decade, with record-high infections, hospitalizations, and a rare second peak.

Acuitas Therapeutics has announced the publication of a new study in Science Immunology, titled "An IL12 mRNA-LNP adjuvant enhances mRNA vaccine-induced CD8 T cell responses." ...

A new article in the peer-reviewed journal Nucleic Acid Therapeutics describes the characterization of antibodies targeting ...

The current dominant variant of COVID-19 has been linked to an increase in cases in the U.S. this summer. A local doctor says ...